The Effect of Inhibiting Glycinamide Ribonucleotide Formyl Transferase on the Development of Neural Tube in Mice

Overview

Journal Nutr Metab (Lond)

Publisher Biomed Central

Date 2016 Aug 25

PMID 27555878

Citations 2

Authors

Lin Xu

Li Wang

Jianhua Wang

Zhiqiang Zhu

Ge Chang

Ying Guo

Xinli Tian

Bo Niu

Affiliations

Soon will be listed here.

Abstract

Background: Folate deficiency is closely related to the development of neural tube defects (NTDs). However, the exact mechanism is not completely understood. This study aims to induce murine NTDs by inhibiting one of the folate metabolic pathways, de novo purine synthesis and preliminarily investigate the potential mechanisms. The key enzyme, glycinamide ribonucleotide formyl transferase (GARFT) was inhibited by a specific inhibitor, lometrexol (DDATHF) in the pregnant mice.

Methods: Pregnant mice were intraperitoneally injected with various doses of DDATHF on gestational day 7.5 and embryos were examined for the presence of NTDs on gestational day 11.5. GARFT activity and levels of ATP, GTP, dATP and dGTP were detected in embryonic brain tissue. Proliferation and apoptosis was analyzed by real-time quantitative polymerase chain reaction (RT-qPCR), immunohistochemical assay and western blotting.

Results: 40 mg kg(-1) body weight (b/w) of DDATHF caused the highest incidence of NTDs (30.8 %) and therefore was selected as the optimal dose to establish murine NTDs. The GARFT activity and levels of ATP, GTP, dATP and dGTP in embryonic brain tissue were significantly decreased after DDATHF treatment. Furthermore, Levels of proliferation-related genes (Pcna, Foxg1 and Ptch1) were downregulated and apoptosis-related genes (Bax, Casp8 and Casp9) were upregulated. Expression of phosphohistone H3 was significantly decreased while expression of cleaved caspase-3 was greatly increased.

Conclusions: Results indicate that DDATHF induced murine NTDs by disturbing purine metabolism and further led to abnormal proliferation and apoptosis.

Citing Articles

Purinosomes and Purine Metabolism in Mammalian Neural Development: A Review.

Yamada S, Mizukoshi T, Sato A, Sakakibara S Acta Histochem Cytochem. 2024; 57(3):89-100.

PMID: 38988694 PMC: 11231565. DOI: 10.1267/ahc.24-00027.

Deletion of the neural tube defect-associated gene disrupts one-carbon and central energy metabolism in mouse embryos.

Bryant J, Sweeney S, Sentandreu E, Shin M, Ipas H, Xhemalce B J Biol Chem. 2018; 293(16):5821-5833.

PMID: 29483189 PMC: 5912453. DOI: 10.1074/jbc.RA118.002180.

References

Prigent C, Dimitrov S . Phosphorylation of serine 10 in histone H3, what for?. J Cell Sci. 2003; 116(Pt 18):3677-85. DOI: 10.1242/jcs.00735. View

Greene N, Copp A . Development of the vertebrate central nervous system: formation of the neural tube. Prenat Diagn. 2009; 29(4):303-11. DOI: 10.1002/pd.2206. View

Chappell Jr J, Wang X, Loeken M . Diabetes and apoptosis: neural crest cells and neural tube. Apoptosis. 2009; 14(12):1472-83. PMC: 5070795. DOI: 10.1007/s10495-009-0338-6. View

Baldwin S, Tse A, Gossett L, Taylor E, Rosowsky A, Shih C . Structural features of 5,10-dideaza-5,6,7,8-tetrahydrofolate that determine inhibition of mammalian glycinamide ribonucleotide formyltransferase. Biochemistry. 1991; 30(7):1997-2006. DOI: 10.1021/bi00221a037. View

Copp A, Greene N, Murdoch J . The genetic basis of mammalian neurulation. Nat Rev Genet. 2003; 4(10):784-93. DOI: 10.1038/nrg1181. View

Sokoloski J, Beardsley G, Sartorelli A . Induction of HL-60 leukemia cell differentiation by the novel antifolate 5,10-dideazatetrahydrofolic acid. Cancer Res. 1989; 49(17):4824-8. View

Copp A, Greene N . Neural tube defects--disorders of neurulation and related embryonic processes. Wiley Interdiscip Rev Dev Biol. 2013; 2(2):213-27. PMC: 4023228. DOI: 10.1002/wdev.71. View

Berry R, Li Z, Erickson J, Li S, Moore C, Wang H . Prevention of neural-tube defects with folic acid in China. China-U.S. Collaborative Project for Neural Tube Defect Prevention. N Engl J Med. 1999; 341(20):1485-90. DOI: 10.1056/NEJM199911113412001. View

Greene N, Copp A . Neural tube defects. Annu Rev Neurosci. 2014; 37:221-42. PMC: 4486472. DOI: 10.1146/annurev-neuro-062012-170354. View

10.

Cong X, Lu C, Huang X, Yang D, Cui X, Cai J . Increased expression of glycinamide ribonucleotide transformylase is associated with a poor prognosis in hepatocellular carcinoma, and it promotes liver cancer cell proliferation. Hum Pathol. 2014; 45(7):1370-8. DOI: 10.1016/j.humpath.2013.11.021. View

11.

Zhong Q, Shi G, Zhang Q, Zhang Y, Levy D, Zhong S . Role of phosphorylated histone H3 serine 10 in DEN-induced deregulation of Pol III genes and cell proliferation and transformation. Carcinogenesis. 2013; 34(11):2460-9. PMC: 3888355. DOI: 10.1093/carcin/bgt219. View

12.

Yamaguchi Y, Miura M . How to form and close the brain: insight into the mechanism of cranial neural tube closure in mammals. Cell Mol Life Sci. 2012; 70(17):3171-86. PMC: 3742426. DOI: 10.1007/s00018-012-1227-7. View

13.

Sanghani S, Moran R . Tight binding of folate substrates and inhibitors to recombinant mouse glycinamide ribonucleotide formyltransferase. Biochemistry. 1997; 36(34):10506-16. DOI: 10.1021/bi970825u. View

14.

Copp A . Neurulation in the cranial region--normal and abnormal. J Anat. 2005; 207(5):623-35. PMC: 1571567. DOI: 10.1111/j.1469-7580.2005.00476.x. View

15.

Zhao H, Liang J, Li X, Yu H, Li X, Xiao R . Folic acid and soybean isoflavone combined supplementation protects the post-neural tube closure defects of rodents induced by cyclophosphamide in vivo and in vitro. Neurotoxicology. 2010; 31(2):180-7. DOI: 10.1016/j.neuro.2009.12.011. View

16.

Zhang L, Ren A, Li Z, Hao L, Tian Y, Li Z . Folate concentrations and folic acid supplementation among women in their first trimester of pregnancy in a rural area with a high prevalence of neural tube defects in Shanxi, China. Birth Defects Res A Clin Mol Teratol. 2006; 76(6):461-6. DOI: 10.1002/bdra.20271. View

17.

Laohavinij S, Wedge S, Lind M, Bailey N, Humphreys A, Proctor M . A phase I clinical study of the antipurine antifolate lometrexol (DDATHF) given with oral folic acid. Invest New Drugs. 1996; 14(3):325-35. DOI: 10.1007/BF00194536. View

18.

Ybot-Gonzalez P, Cogram P, Gerrelli D, Copp A . Sonic hedgehog and the molecular regulation of mouse neural tube closure. Development. 2002; 129(10):2507-17. DOI: 10.1242/dev.129.10.2507. View

19.

Thorndike J, Kisliuk R, Gaumont Y, Piper J, Nair M . Tetrahydrohomofolate polyglutamates as inhibitors of thymidylate synthase and glycinamide ribonucleotide formyltransferase in Lactobacillus casei. Arch Biochem Biophys. 1990; 277(2):334-41. DOI: 10.1016/0003-9861(90)90588-p. View

20.

Xiao R, Yu H, Zhao H, Liang J, Feng J, Wang W . Developmental neurotoxicity role of cyclophosphamide on post-neural tube closure of rodents in vitro and in vivo. Int J Dev Neurosci. 2007; 25(8):531-7. DOI: 10.1016/j.ijdevneu.2007.09.012. View